Evidence map›Paper›PMID 26467510›Full record

ArticleHuman vaccines & immunotherapeutics2016

Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study.

Huachun Zou, Xiaojun Meng, Tianjian Jia, Chen Zhu, Xin Chen, Xiaolin Li, Junjie Xu, Wei Ma, Xuan Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Huachun Zoua Kirby Institute, University of New South Wales , Sydney , Australia.
Xiaojun Mengb Wuxi Municipal Centre for Disease Control and Prevention , Wuxi , Jiangsu Province , China.
Tianjian Jiab Wuxi Municipal Centre for Disease Control and Prevention , Wuxi , Jiangsu Province , China.
Chen Zhuc Nanchang District Centre for Disease Control and Prevention , Wuxi , Jiangsu Province , China.
Xin Chenc Nanchang District Centre for Disease Control and Prevention , Wuxi , Jiangsu Province , China.
Xiaolin Lid Shanghai Entry-Exit Inspection and Quarantine Bureau , Shanghai , China.
Junjie Xue The First Affiliated Hospital, China Medical University , Shenyang , China.
Wei Maf Department of Epidemiology and Health Statistics , School of Public Health, Shandong University , Jinan , Shandong Province , China.
Xuan Zhangb Wuxi Municipal Centre for Disease Control and Prevention , Wuxi , Jiangsu Province , China.
Nanjing Municipal Center for Disease Control And Prevention · CNNanchang Center for Disease Control and Prevention · CNChina Medical University · CNShandong University · CNShanghai Entry-Exit Inspection and Quarantine Bureau · CNUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo study the awareness and acceptance of human papillomavirus (HPV) vaccination among sexually active men having sex with men (MSM) and men not having sex with men (MNSM) attending the largest sexual health clinic in Wuxi, China.

methodsA questionnaire about participants' socio-demographic characteristics and view on HPV vaccination was collected.

resultsA total of 186 MSM and 182 MNSM were recruited. Among MSM, 12.4% were under 20 years old, 64.5% never married and 56.5% from Jiangsu Province (where Wuxi City is located); 64.0% had resided in Wuxi for over 2 years, 64.5% had high school education or more, and 83.9% had an income of 5000 RMB or less per month compared to figures of 5.5%, 50.6%, 73.6%, 54.9%, 86.8% and 64.8% among MNSM, respectively (All P values < 0.05). Among these 2 groups of men, 18.4% and 23.1% had heard of HPV; 10.2% and 15.4% had heard of HPV vaccine; and 26.2% and 20.2% would take HPV vaccine before sexual debut, respectively. MNSM were significantly more willing to take HPV vaccine than MSM (70.9 vs 34.9%, p < 0.001). Factors associated with HPV vaccine acceptance among MSM included engaging mostly in receptive anal sex (Odds ratio (OR)=3.9, 95% Confidence interval (CI): 1.8-13.5), never using a condom in anal sex in the past 6 months (3.5, 1.5-20.2), ever diagnosed with a sexually transmitted infection (STI) (3.4, 1.3-8.4) and ever receiving HIV related services (1.6, 1.1-4.4). Among MNSM these Factors included commercial sex with women (1.7, 1.2-8.6), never using a condom in commercial sex (1.6, 1.4-7.6) and STI diagnosis (2.0, 1.6-7.3).

conclusionsSexually active MSM and MNSM in Wuxi lacked knowledge of HPV and HPV vaccination. The majority of these at-risk men would not benefit from HPV vaccination as their age at first sex proceeded perceived age of vaccine uptake. Aggressive education aimed at increasing knowledge of HPV and HPV vaccination among these men is warranted.

Indexed as

Health Knowledge, Attitudes, PracticePatient Acceptance of Health CareAdolescentAdultChinaCross-Sectional StudiesHumansMaleMiddle AgedPapillomavirus InfectionsPapillomavirus VaccinesSurveys and QuestionnairesVaccinationYoung AdultPapillomavirus VaccinesacceptanceawarenessChinaHPV vaccinemen having sex with menmen not having sex with men

Identifiers

PMID26467510
PMCPMC4964713
OpenAlexW2278645481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.